Welcome

Devyser invites analysts, investors and financial media to a Capital Markets Day November 25, 2024.

Presentations will start at 13:30 CET and are expected to go on until 16:00 CET followed by an optional tour of the new facilities.

We will provide a comprehensive overview of our business operations, strategies, and future growth plans. The program will include presentations by the Devyser executive management team as well as key external speakers.

We will also showcase our new facilities, highlighting the increased capacity and potential for expansion that these spaces offer. By opening our doors and providing a firsthand look at our operations and new facilities, we aim to demonstrate our commitment to innovation, efficiency, and sustainable growth as well as engage in meaningful dialogue with our investors.

Place: Devyser HQ, Bränningevägen 12, Årsta, Stockholm.

Time: 13:30 CET, November 25, 2024.

Agenda:

13.30-13.45

Welcome & Introduction

Fredrik Alpsten
| CEO Devyser
13.45-14.00

Product portfolio Overview

Michael Uhlin
| CSO Devyser
14.00-14.20

The Devyser commercialization plan

Theis Kipling
| CCO Devyser
14.20-14.40

North America in Focus

Jeff Salzman
| VP Market Access & Public Affairs US
14.40-15.00

Coffee Break & mingle
15.00-15.30

Monitoring of donor derived cell free DNA post transplantation

Jakob Nilsson M.D., Ph.D.
| Director Transplant Immunology, Consultant Physician, Department of Immunology University Hospital Zurich, Switzerland
15.30-15.40

Closing remarks

Fredrik Alpsten
| CEO Devyser
15.40-16.00

Q&A
16.10-16.30

Ending with an optional tour

We hope you will be able to join us in person. There are limited seats at the event so make sure to reserve your seat via the registration above if you want to attend in person.

The event will also be available online on-demand once the on-site event has been concluded (approx at 17:30 CET).